| CASE REPORT |
|
| Year : 2022 | Volume
: 14
| Issue : 4 | Page : 135-137 |
|
|
Recovery of resistant alopecia areata treated with tofacitinib: An 8-year-old child's case report
Anil Bhokare
Apex Skin and Laser Center, Opposite M. S. G. College, Nasik, Maharashtra, India
Correspondence Address:
Anil Bhokare
Apex Skin and Laser Center, Opposite M.S.G. College, Near MG Petrol Pump, Malegaon, Nasik - 423 203, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijt.ijt_15_22
|
|
|
Tofacitinib has been reported to activity in the recovery of alopecia areata (AA) in several reports, mainly from Western countries. We report the case of a young Indian boy with resistant AA who was treated with tofacitinib-based therapy. Improvements in terms of hair regrowth were observed within 6–8 weeks of treatment with oral tofacitinib 2.5 mg BID tablets, and the hair regrowth was nearly complete by 5 months. There were no associated side effects and the treatment with tofacitinib was well-tolerated.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
